Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study
Titel:
Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study
Auteur:
Pierga, Jean-Yves Petit, Thierry Delozier, Thierry Ferrero, Jean-Marc Campone, Mario Gligorov, Joseph Lerebours, Florence Roché, Henri Bachelot, Thomas Charafe-Jauffret, Emmanuelle Pavlyuk, Maria Kraemer, Sandrine Bidard, François-Clément Viens, Patrice